Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Devroe Eric
Chief Operating Officer at Acrivon Therapeutics. Filing since 13 Jan 2026.
CIK 0001950573
Company
Date
Role
Action
Shares
Amount
Of holding
ACRV
Acrivon Therapeutics, Inc.
18 Aug 2026
Chief Operating Officer
Sold at will
604
$1.21K
0.4%
ACRV
Acrivon Therapeutics, Inc.
13 Jan 2026
Chief Operating Officer
Bought
10,000
$17.22K
15.3%
2 decisions on file.